IDEXX Laboratories Aktie

IDEXX Laboratories für 0 Euro bei ZERO ordern (zzgl. Spreads)

WKN: 888210 / ISIN: US45168D1046

<
Kurse + Charts + Realtime
Kurs + Chart
Times + Sales
Börsenplätze
Historisch
>
<
News + Analysen
News + Adhoc
Analysen
Kursziele
>
<
Unternehmen
Termine
Profil
>
<
zugeh. Wertpapiere
Zertifikate
Optionsscheine
Knock-Outs
>
02.05.2023 12:40:47

IDEXX Laboratories Inc Q1 Income Advances, Beats estimates

(RTTNews) - IDEXX Laboratories Inc (IDXX) released a profit for its first quarter that increased from the same period last year and beat the Street estimates.

The company's bottom line came in at $214.05 million, or $2.55 per share. This compares with $193.97 million, or $2.27 per share, in last year's first quarter.

Analysts on average had expected the company to earn $2.42 per share, according to figures compiled by Thomson Reuters. Analysts' estimates typically exclude special items.

The company's revenue for the quarter rose 7.6% to $900.20 million from $836.55 million last year.

IDEXX Laboratories Inc earnings at a glance (GAAP) :

-Earnings (Q1): $214.05 Mln. vs. $193.97 Mln. last year. -EPS (Q1): $2.55 vs. $2.27 last year. -Analyst Estimate: $2.42 -Revenue (Q1): $900.20 Mln vs. $836.55 Mln last year.

-Guidance: Full year EPS guidance: $9.33 - $9.75 Full year revenue guidance: $3,615 - $3,700 Mln

Analysen zu IDEXX Laboratoriesmehr Analysen

Eintrag hinzufügen
Hinweis: Sie möchten dieses Wertpapier günstig handeln? Sparen Sie sich unnötige Gebühren! Bei finanzen.net Brokerage handeln Sie Ihre Wertpapiere für nur 5 Euro Orderprovision* pro Trade? Hier informieren!
Es ist ein Fehler aufgetreten!

Aktien in diesem Artikel

IDEXX Laboratories 463,00 1,18% IDEXX Laboratories